Variable | Mean survival time (months) | 1-year OS | 3-year OS | 5-year OS | P value |
Site of recurrence |
|
|
|
| <0.001 |
Intrahepatic | 56.1 ± 3.3 | 73.4% | 37.0% | 27.2% |
|
Extrahepatic | 24.2 ± 3.8 | 68.6% | 20.6% | 0 |
|
Intrahepatic and extrahepatic | 20.0 ± 4.4 | 57.1% | 3.3% | 0 |
|
Tumor nodules |
|
|
|
| <0.001 |
Single | 72.3 ± 4.8 | 81.8% | 46.5% | 39.2% |
|
Mutiple | 31.2 ± 2.9 | 61.3% | 20.9% | 10.1% |
|
Tumor thrombus |
|
|
|
| <0.001 |
Yes | 18.0 ± 4.7 | 40.0% | 10.0% | 5.0% |
|
No | 55.6 ± 3.2 | 74.7% | 36.3% | 26.7% |
|
Clinical stages |
|
|
|
| <0.001 |
Early stage | 70.7 ± 4.7 | 82.0% | 46.8% | 37.3% |
|
Intermediate stage | 42.8 ± 5.7 | 73.2% | 31.8% | 15.9% |
|
Advanced stage | 25.1 ± 3.1 | 55.5% | 14.2% | 0 |
|
Terminal stage | 6.5 ± 3.4 | 10.0% | 0 | 0 |
|
Treatment strategies |
|
|
|
| <0.001 |
RR | 73.0 ± 8.1 | 94.0% | 48.5% | 38.4% |
|
LAT | 83.1 ± 9.3 | 84.7% | 52.0% | 16.7% |
|
TACE | 47.3 ± 3.6 | 67.3% | 30.1% | 21.2% |
|
Radiotherapy | 27.0 ± 7.0 | 64.7% | 11.8% | 0 |
|
Palliative treatment | 11.3 ± 2.2 | 34.4% | 3.1% | 0 |
|
Disease-free interval |
|
|
|
| <0.001 |
≤1 year | 37.9 ± 3.0 | 60.5% | 23.9% | 16.1% |
|
>1 years | 73.6 ± 9.2 | 91.8% | 52.9% | 39.5% |
|